Raymond James raised its price target for Alpha Cognition (TSXV:ACOG) to $3.50 (Canadian) from $2.50 and maintained its “outperform” rating after the FDA accepted Alpha’s IND application to proceed into a pivotal...
Raymond James upgraded HLS Therapeutics (TSX:HLS) to “outperform” from “market perform” and raised its price target to $26 (Canadian) from $24 after Pfizer agreed to co-market HLS’s cardiovascular drug...
Raymond James initiated coverage of Alpha Cognition (TSXV:ACOG) with an “outperform” rating and price target of $2.50 (Canadian). The stock closed at 80 cents on June 2. Alpha is in the late stages of clinical...
Raymond James upgraded Cardiol Therapeutics (TSX:CRDL) to “outperform” from “market perform,” citing enrollment of the first patient in a Phase 2/3 clinical trial investigating the cardioprotective properties of...
Raymond James raised its price target for Perimeter Medical Imaging (TSXV:PINK) to $6.50 (Canadian) from $3, citing a deeper look at the artificial intelligence-enabled application of the company’s Optical...
Raymond James initiated coverage of Skylight Health Group (TSXV:SHG) with an “outperform (2)” ranting and $2.25 (Canadian) target price. The stock closed at $1.66 on Feb. 23. Skylight operates a large and growing U.S...
Raymond James raised its price target for Protech Home Medical (TSXV:PTQ) to $3 (Canadian) from $2.00, citing an update to its valuation methodology. The stock closed at $2.05 on Jan. 21. Protech is a provider of...
Raymond James initiated coverage of Protech Home Medical (PTQ-TSXV) with an “outperform” rating and price target of $2 (Canadian). The stock closed at $1.44 on Dec. 14. Protech provides clinical respiratory equipment...
Raymond James initiated coverage of Perimeter Medical Imaging AI (TSXV:PINK) with an “outperform” rating and price target of $3 (Canadian). The stock closed at $2.19 on Nov. 6. Perimeter is commercializing its Optical...
Raymond James reiterated that Profound Medical (TSX:PRN; NASDAQ:PROF) remains its “analyst current favorite” and “2020 Best Pick,” saying Profound is “particularly insulated from the current economic fallout of COVID-19...